No Picture
News

BD announces another expansion, this time in San Diego

Amidst a push to ease pressure on the supply chain domestically, BD Biosciences will expand at the San Diego Reagent Innovation Center, as the property developer announced the company’s plans Monday. The San Diego site will be at Torrey View, a 10-acre life sciences R&D campus that Breakthrough Properties is…… Click here to view original post… […]

No Picture
News

Neurana Pharmaceuticals to Present at Piper Sandler Healthcare Conference

SAN DIEGO: SAN DIEGO, Nov. 24, 2021 /PRNewswire/ — Neurana Pharmaceuticals, a biotechnology company focused on the treatment of neuromuscular conditions, today announced that Craig Thompson, President and Chief Executive Officer, will present at the 33rd Annual Piper Sandler Healthcare Conference and participate in one-on-one meetings with investors. The conference… Click here to view original post… […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

AcelRx Pharmaceuticals Announces the Appointment of Jill Broadfoot to its Board of Directors

HAYWARD, Calif.: HAYWARD, Calif., Nov. 23, 2021 /PRNewswire/ — AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced the appointment of Jill Broadfoot to the company’s Board of Directors. Ms. Broadfoot currently serves… Click here to view original post… […]

No Picture
News

Palisade Bio Announces Inducement Awards Under Inducement Plan for Key New Hires, Including Nick McCoy, Vice President of Clinical Operations

CARLSBAD, Calif., Nov. 23, 2021 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (NASDAQ: PALI), a clinical stage biopharmaceutical company advancing oral therapies that help patients with acute and chronic gastrointestinal (GI) complications (the “Company”), today announced that it had made equity grants to three new employees under its 2021 Inducement Plan (the… Click here to view original post… […]

No Picture
News

Mirati Therapeutics to Participate in the 4th Annual Evercore ISI HealthCONx Conference

SAN DIEGO: SAN DIEGO, Nov. 23, 2021 /PRNewswire/ — Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, will take part in a fireside chat at the Evercore ISI HealthCONx Conference, which will be webcast on December 2 at 11:15 a.m. P.T. / 2:15 p.m. E.T. David Meek, chief… Click here to view original post… […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Shoreline Biosciences To Present At Two Upcoming Investor Conferences

SAN DIEGO: SAN DIEGO, Nov. 23, 2021 /PRNewswire/ — Shoreline Biosciences, Inc. (Shoreline), a biotechnology company developing intelligently designed allogeneic off-the-shelf, standardized, and targeted induced pluripotent stem cells (iPSC) derived natural killer (NK) and Macrophage cellular immunotherapies, today announced that company management will present and conduct one-on-one meetings at the… Click here to view original post… […]

No Picture
News

Neurobiologists Reveal How Value Decisions are Coded into Our Brains

A new study is showing how value choices are recorded in our brains. Researchers found that persistency allows value signals to be most effectively represented, or “coded,” across different areas of the brain, especially in a critical area within the cerebrum known as the retrosplenial cortex…. Click here to view original post… […]

No Picture
News

Neurophth Raised Over $60 Million USD in Series-C Financing to Advance Gene Therapies

SAN DIEGO: SAN DIEGO, Nov. 23, 2021 /PRNewswire/ — Neurophth Therapeutics Ltd., ("Neurophth"), a fully integrated genomic medicines company dedicated on seeking to improve lives through the curative potential of gene therapies, today announced the closing of over $60 million USD in Series-C financing with a premier syndicate of investors,… Click here to view original post… […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Aptose to Present at the Piper Sandler 33rd Annual Healthcare Conference

SAN DIEGO and TORONTO, Nov. 22, 2021 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, today announced that the Aptose management team will be participating in the Piper Sandler 33rd Annual Healthcare Conference,… Click here to view original post… […]

No Picture
News

DNAtrix Announces Oral Presentation of Positive Overall Survival Data with DNX-2401 in DIPG at the Society for Neuro-oncology (SNO) Annual Meeting

SAN DIEGO: SAN DIEGO, Nov. 22, 2021 /PRNewswire/ — DNAtrix, a biotech company advancing virus-driven immunotherapies for cancer, today announced that data from the Phase 1 study of DNX-2401 in diffuse intrinsic pontine glioma (DIPG) was presented in an oral presentation at the 26th Annual Meeting and Education Day of… Click here to view original post… […]

No Picture
News

Sorrento Therapeutics Mexico Executes Contract for Sale of 5 Million COVI-STIX Tests for Mexico Market

SAN DIEGO and MEXICO CITY, Nov. 22, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) announced today its subsidiary, Sorrento Therapeutics Mexico, has executed a contract with a leading local distributor for the sale and distribution of up to 5 million COVI-STIX™ tests for the Mexican market…. Click here to view original post… […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Connect Biopharma Expands Executive Leadership Team with Hire of Chief Financial Officer

SAN DIEGO, CA and TAICANG, SUZHOU, China, Nov. 22, 2021 (GLOBE NEWSWIRE) — Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases through the… Click here to view original post… […]

No Picture
News

COVID Gets Airborne

In May 2021, the Centers for Disease Control officially recognized that SARS-CoV-2—the virus that causes COVID-19—is airborne. Now UC San Diego Professor and Endowed Chair of Chemistry and Biochemistry Rommie Amaro has modeled the delta virus inside an aerosol for the first time. Click here to view original post… […]

No Picture
News

COVID Gets Airborne

In May 2021, the Centers for Disease Control officially recognized that SARS-CoV-2—the virus that causes COVID-19—is airborne. Now UC San Diego Professor and Endowed Chair of Chemistry and Biochemistry Rommie Am… […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

EpicentRx Granted New Composition of Matter Patent for Its TGF-ß Trap Fusion Protein

LA JOLLA, Calif.: LA JOLLA, Calif., Nov. 22, 2021 /PRNewswire/ — EpicentRx, Inc., a clinical-stage biotechnology company at the forefront of oncolytic viruses and small molecules for the treatment of cancer and other inflammatory-driven diseases, today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent… Click here to view original post… […]

No Picture
News

How Well Do Wet Masks Contain Droplets?

A team of international researchers modeled what happens to respiratory droplets when they come in contact with wet masks; their results show that damp masks are still effective at stopping these droplets from e… […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

LifeVoxel.AI Raises $5 Million Seed Round for its AI Diagnostic Visualization Platform

SAN DIEGO: SAN DIEGO, Nov. 22, 2021 /PRNewswire/ — LifeVoxel.AI, a San Diego based medical platform for AI and Visualization, today announced it has raised a $5 million seed funding. LifeVoxel’s patented technologies empower instant and ubiquitous access to interactive imaging studies and data, with zero latency and zero client… Click here to view original post… […]

No Picture
News

Neurocrine Biosciences and Sosei Heptares Announce Collaboration to Develop Novel Muscarinic Receptor Agonists for Schizophrenia and Other Neuropsychiatric Disorders

SAN DIEGO and TOKYO and CAMBRIDGE, England: SAN DIEGO and TOKYO and CAMBRIDGE, England, Nov. 22, 2021 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) and Sosei Group Corporation ("Sosei Heptares"; TSE: 4565) announce the signing of a strategic collaboration and licensing agreement to develop novel muscarinic receptor agonists, which Neurocrine… Click here to view original post… […]

No Picture
News

Mirati Therapeutics and Verastem Oncology Partner to Evaluate Adagrasib in Combination with VS-6766 in KRASG12C-Mutant Non-Small Cell Lung Cancer

SAN DIEGO and BOSTON: SAN DIEGO and BOSTON, Nov. 22, 2021 /PRNewswire/ — Mirati Therapeutics, Inc. (Nasdaq:MRTX), a clinical-stage targeted oncology company and Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced a non-exclusive clinical collaboration agreement to evaluate the combination of… Click here to view original post… […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Aloisia Beauty™ Debuts Two New Mini Skincare Sets Just in Time for the Holidays

SAN DIEGO: SAN DIEGO, Nov. 22, 2021 /PRNewswire-PRWeb/ — Aloisia Beauty™, the clean skincare brand that blends Korean beauty philosophies and ingredients with innovation, announces the launch of RESTORE MINI Set and CLEANSE & GLOW MINI Set. Both sets offer a curated selection of Aloisia Beauty’s best-selling products in travel-friendly,… Click here to view original post… […]

No Picture
News

Evofem Biosciences Successfully Extends Cumulative Net Sales Covenant Timing to June 30, 2023

SAN DIEGO: SAN DIEGO, Nov. 22, 2021 /PRNewswire/ — Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that it has successfully extended the cumulative net sales covenant timing of its April 2020 Securities Purchase and Security Agreement to June 30, 2023. "We appreciate that these healthcare investors see the potential for… Click here to view original post… […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Connect Biopharma Completes Enrollment of CBP-307 Global Phase 2 Clinical Trial in Moderate-to-Severe Ulcerative Colitis

SAN DIEGO, CA and TAICANG, SUZHOU, China, Nov. 19, 2021 (GLOBE NEWSWIRE) — Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases through the… Click here to view original post… […]

No Picture
News

Reading the mind of a worm

LA JOLLA—It sounds like a party trick: scientists can now look at the brain activity of a tiny worm and tell you which chemical the animal smelled a few seconds before. But the findings of a new study, led by Salk Associate Professor Sreekanth Chalasani, are more than just… Click here to view original post… […]

No Picture
News

Oncolytics Biotech® to Present Phase 2 Triple-Negative Breast Cancer Trial Update at the 2021 San Antonio Breast Cancer Symposium

SAN DIEGO and CALGARY, AB: IRENE study is evaluating pelareorep-anti-PD-1 combination treatment in metastatic TNBC SAN DIEGO and CALGARY, AB, Nov. 19, 2021 /PRNewswire/ — Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that the Company will present an update on the Phase 2 IRENE trial in a poster… Click here to view original post… […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Viridos Executes Agreement with ExxonMobil to Help Scale Algae Biofuels

LA JOLLA, Calif.–(BUSINESS WIRE)–Viridos Inc., previously Synthetic Genomics, a privately held biotechnology company harnessing the power of photosynthesis to create transformative solutions to help mitigate climate change, has signed a joint development agreement with ExxonMobil Research and Engineering Company (“ExxonMobil”) with the intent to bring Viridos’ low-carbon intensity biofuels toward… Click here to view original post… […]

No Picture
News

Takeda oncology vet drills down the ‘basics’ at cell therapy startup; Sarepta promotes new R&D chief

Kathryn Corzo Kathryn Corzo — an oncology veteran and the program head behind Sanofi’s multiple myeloma monoclonal antibody isatuximab — is now in the C-suite. The newest member at cell therapy player bit.bio as their COO, the longtime drug developer left Takeda… Click here to view original post… […]

No Picture
News

ASRA 2021 | Cali Biosciences Presents Phase IIa Clinical Data on CPL-01, a Long-Acting Ropivacaine

SAN DIEGO: SAN DIEGO, Nov. 19, 2021 /PRNewswire/ — Cali Biosciences, a global biopharmaceutical company focused on the research and development of innovative drugs, presented Phase IIa clinical data today on its perioperative long-acting ropivacaine, CPL- 01, at the 20th Annual American Society of Regional Anesthesia and Pain Medicine (ASRA)… Click here to view original post… […]